Lopez-Herce J, Dorao P, Delgado M A, Espinosa L, Ruza F, Martinez M C
Pediatric Intensive Care Unit, La Paz Children's Hospital, Madrid, Spain.
Intensive Care Med. 1989;15(4):224-7. doi: 10.1007/BF00271055.
Continuous arteriovenous haemofiltration (CAVH) was used in 7 critically ill children: a premature neonate with hypervolaemia secondary to hydrops foetalis and six children aged 9 days to 7 years with acute oliguric renal failure. Biospal 0.5 m2, Renaflo 0.25 m2, Gambro 0.15 m2 and Amicon 0.015 m2 filters were used according to the weights and ages of the patients. Adequate removal of water and solutes was obtained in 6 patients. One of the patients with the smallest filter needed a change to a filter with a larger surface area to improve water and solute removal. Haemofiltration was maintained for between 17 hours and 31 days and was well tolerated. CAVH was discontinued because of recovery of renal function in three patients, improvement of the hypervolaemic state in one, death in three, and transfer to continuous ambulatory peritoneal dialysis because of chronic renal failure in one patient. CAVH is a useful technique for the treatment of acute renal failure and hypervolaemia in critically ill children.
对7名危重症儿童采用了持续动静脉血液滤过（CAVH）治疗：1名因胎儿水肿继发高血容量的早产新生儿，以及6名年龄在9天至7岁之间的急性少尿性肾衰竭儿童。根据患者的体重和年龄，分别使用了Biospal 0.5 m²、Renaflo 0.25 m²、Gambro 0.15 m²和Amicon 0.015 m²的滤器。6例患者实现了水和溶质的充分清除。其中1例使用最小滤器的患者需要更换为更大表面积的滤器，以改善水和溶质清除效果。血液滤过持续了17小时至31天，耐受性良好。3例患者因肾功能恢复而停止CAVH，1例因高血容量状态改善而停止，3例死亡，1例因慢性肾衰竭转至持续非卧床腹膜透析。CAVH是治疗危重症儿童急性肾衰竭和高血容量的一项有用技术。
